Samuel R Saks Insider Trading $TNXP Tonix Pharmaceuticals Holding Corp.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Samuel R Saks.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Samuel R Saks. Samuel R Saks is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in DEPOMED INC ($DMI) and Chief Development Officer in Protagonist Therapeutics, Inc ($PTGX) and Chief Medical Officer in Protagonist Therapeutics, Inc ($PTGX) and Director in Tonix Pharmaceuticals Holding Corp. ($TNXP) and Chief Development Officer in Auspex Pharmaceuticals, Inc. ($ASPX).
Samuel R Saks in Tonix Pharmaceuticals Holding Corp.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Samuel R Saks: Director
Holdings: 6,605 shares
Current Value: $3,501
Latest Transaction: Jun 13 2018
$TNXP Market Capitalization: $21.31M
$TNXP Previous Close: $0.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Samuel R Saks in Tonix Pharmaceuticals Holding Corp.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DMI, ASPX, PDLI, PTGX, TNXP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | A | 4.25 | 20,000 | 85,000 | 20,000 | |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | M | 0.00 | 650 | 0 | 0 | |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Buy | M | 0.00 | 600 | 0 | 3,855 | 3.3 K to 3.9 K (+18.43 %) |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Buy | M | 0.00 | 750 | 0 | 5,855 | 5.1 K to 5.9 K (+14.69 %) |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Buy | M | 0.00 | 750 | 0 | 6,605 | 5.9 K to 6.6 K (+12.81 %) |
| Jun 21 2017 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | A | 4.18 | 20,000 | 83,600 | 20,000 | |
| Jun 21 2016 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Buy | P | 2.00 | 25,000 | 50,000 | 63,550 | 38.6 K to 63.6 K (+64.85 %) |
| May 31 2016 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Feb 10 2016 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Jul 17 2015 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Buy | P | 7.50 | 10,000 | 75,000 | 32,550 | 22.6 K to 32.6 K (+44.35 %) |
| Feb 27 2015 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| Feb 27 2015 | TNXP | Tonix Pharmaceutic ... | Saks Samuel R | Director | Option Exercise | A | 5.95 | 5,000 | 29,750 | 5,000 |
Page: 1